TEL: 044-952-0102


Scrip (Pharma Intelligence)

発行 SCRIP 商品コード 404564
出版日 年間契約型情報サービス ページ情報 英文
本日の銀行送金レート: 1USD=108.31円で換算しております。
Scrip:創薬・開発・製品ライフサイクルに関するニュース分析サービス Scrip (Pharma Intelligence)
出版日: 年間契約型情報サービス ページ情報: 英文
世界中の製薬会社に広く知れ渡る情報誌です。日々更新されるオンラインサービス及び毎週25ページ程度PDFの形式でお届けするサービスです。HEADLINE NEWSでは製薬会社における最新の製品発表、活動報告などがまとめられており、他、キーパーソンへのInterview、R&D BITES、POLICY & REGULATION BRIEFS、BUSINESS BULLETIN、STOCKWATCH等の区分で世界の最新実情をお届けします。最新Issueをお送りしますので無料サンプルよりまずはお申込み下さい。





  • ▼ 20名以上のアナリストがリアルタイムなニュース分析を公開
  • ▼ 目的に合わせたEメール通知機能
  • ▼ 最先端企業の徹底調査から読み解く、新傾向やテクノロジーの評価
  • ▼ 新製品戦略の推進に欠かせない製品開発情報の充実
  • ▼ Scrip Pipeline Watchで主要競合他社の研究開発進捗を把握
  • ▼ 主要なオピニオンリーダーへのインタビュー


  • ■検索機能
    • ニュース、マーケットデータなどのフォーマット別検索フィルターに加え、アドバンスサーチ機能を使った期間、カテゴリー等の細かい検索も可能です。
  • ■デイリーアラート
    • 毎日ヘッドラインをメールで配信します。
  • ■ニューズレター
    • 毎週金曜日、その週の注目記事をPDFにて配信します。
    • 過去のニューズレターもPDFライブラリーからご覧いただけます。
  • ■Ask the Analystサービス
    • 当サービスが配信する記事について、疑問点をアナリストへ質問いただけます。アナリストが直接回答いたします。
    • 追加料金は一切かかりません。




Scrip brings you market intelligence that goes beyond the headlines and focusses on delivering insight and analysis on the whole of the drug discovery, development and product life cycle value chain. Scrip gives you access to the latest licensing opportunities, partnership deals, company developments and constantly tracks product approvals across multiple therapy areas and product types.

With an unparalleled global network of contributors, Scrip is the trusted, comprehensive source of business critical market and competitor insights for the commercial pharmaceutical industry. It delivers deep insights and analysis about global commercial, business and finance developments and is the go-to- source for the industry.

What's new?

A subscription will give you increased content direct from editorial bureaus in China, India, Japan, Korea, Australia and the Pacific Rim with daily analysis of critical developments in these and other key markets in the AP region.

With access to English-language summaries of news about your company and competitors from the Chinese and Japanese press, you'll always be kept well informed on these and other key emerging markets.

Scrip now also publishes in-depth profiles of leading-edge start-up companies including new trends in business, technology, and financing. This will help you to identify new investment opportunities, create technology/product ideas and help you understand key trends in company start-ups and plan strategically for the future.

Leading industry insight on a leading industry platform

What's more, Scrip is published on a new user-friendly, interactive and responsive website. It allows you to access a large amount of relevant content from one place. The ability to create custom email alerts, numerous ways to refine and target search results, and simple tools to collect, send and share content allows you to tailor the service to your exact requirements.

Related articles, deals, companies, regions, therapy areas and other subjects are listed on the same page. This means that you can identify, find and read the content without having to look for it, making the website a valuable time saving resource.

Subscribe today and get access to:

  • Over 20 global analysts publishing real-time analysis accessible on mobile, tablet and PC.
  • Unique perspective from the US, Europe and developments in Asia Pacific.
  • In-depth profiles of leading-edge companies assessing new trends and technologies
  • Company Developments: Including M&A, deals, financial results, partnerships and more.
  • Product Developments: Including clinical trial results, approvals, launches, and postmarketing updates - so you can drive your own new product strategy.
  • Scrip Pipeline Watch: R&D progress for essential competitor data and drug strategy development.
  • Trend Spotting - Market Access and Therapeutic Areas: reporting from key conferences; interviews with key opinion leaders.
  • Unique access to Informa's suite of Pharma intelligence databases provide exclusive overviews and market forecasts so you can monitor target disease areas and compare strategies for pricing and reimbursement.
  • Financial Markets: Stockwatch column with our unique view of developments and activities and how they impact share prices and deals.
  • Scrip 100 - Dive deep into company analysis with Scrip 100, our annual ranking of the top 100 pharmaceutical companies in the world.
  • Scrip Asia 100 that dissects who's who in the growing APAC region annually.
  • Scan headlines to be up on the latest, and tailor the service to your specific needs with refined targeted searches, and custom email alerts and RSS feeds so you never miss a development.
  • “Ask the Analyst” exclusive client service to find out more about market access topics, developments, or trends to support presentations, proposals, or business critical decisions where your credibility is on the line.